The Vanguard Group, Inc. has recently announced that it has increased stake in Alkermes plc (NASDAQ:ALKS) by 0.29%. After grabbing 18.15 million shares, the institutional investor is now in possession of 52745.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 10.93% having worth around $518.25 million. Moreover, Wellington Management Co. LLP increased its share by 0.67 million to have a control over 6.71 million shares. And Hardman Johnston Global Advisors raised its holdings to 0.45 million shares by acquiring 6.01 million shares or 3.62% of the stake.
Alkermes plc (ALKS) concluded trading on 05/25/23 at a closing price of $29.38, with 0.94 million shares of worth about $27.48 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.92% during that period and on Thursday the price saw a gain of about 0.10%. Currently the company’s common shares owned by public are about 165.09M shares, out of which, 161.64M shares are available for trading.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 94 times over the past 12 months. They bought 533,964 shares in 49 of the transactions. In 45 selling transactions, insiders dumped 170,034 shares.
Vanguard Total Stock Market ETF, Hardman Johnston Global Equity, and Vanguard Health Care Fund are the top 3 mutual funds which are holding stakes in Alkermes plc Vanguard Total Stock Market ETF is currently holding 5.13 million shares of worth totaling $146.59 million. The company recently came buying 40831.0 shares which brought its stake up to 3.09% of the company’s outstanding shares. Vanguard Health Care Fund, after buying 4.62 million shares, have now control over 2.78% of the stake in the company. It holds 0.0 shares of worth $131.9 million.
Alkermes plc (NASDAQ: ALKS) started trading at $29.22, below -$0.13 from concluding price of the previous day. However, the stock later moved at a day high price of 29.66, or with a gain of 0.10%. Stock saw a price change of -2.65% in past 5 days and over the past one month there was a price change of 3.52%. Year-to-date (YTD), ALKS shares are showing a performance of 12.44% which increased to 3.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $21.75 but also hit the highest price of $32.23 during that period. The average intraday trading volume for Alkermes plc shares is 1.25 million. The stock is currently trading -1.97% below its 20-day simple moving average (SMA20), while that difference is up 1.66% for SMA50 and it goes to 12.78% higher than SMA200.
The Vanguard Group, Inc. acquired 18.15 million shares of Alkermes plc having value of about $518.25 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 52745.0 shares in the company valued at close to $1549648.1, or have control over 0.29% stake in the company. Alkermes plc (NASDAQ: ALKS) currently have 165.09M outstanding shares and institutions hold larger chunk of about 99.60% of that. Holding of mutual funds in the company is about 49.72% while other institutional holders and individual stake holders have control over 52.57% and 1.79% of the stake respectively.
The stock has a current market capitalization of $4.83B and its 3Y-monthly beta is at 0.60. It has posted earnings per share of -$1.00 in the same period. It has Quick Ratio of 1.90 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALKS, volatility over the week remained 1.95% while standing at 2.23% over the month.
Analysts are in expectations that Alkermes plc (ALKS) stock would likely to be making an EPS of $0.01 in the current quarter, while forecast for next quarter EPS is $0.02 and it is $1.44 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.03 which is $0.05 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.06 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -223.30% while it is estimated to increase by 1768.83% in next year. EPS is likely to grow at an annualized rate of 24.80% for next 5-years, compared to annual growth of -1.70% made by the stock over the past 5-years.
